2011
Extensive product development planning
![2011<br/><span style="color:#000">Extensive product development planning</span>](https://luodapharma.com/wp-content/uploads/2017/05/405375142-350x120.jpg)
Dr Stephen Page, a leading veterinary pharmacologist, with a successful background with big pharma, kick starts the pre-clinical studies of Luoda’s pipeline
2013
BioSA grant to support novel dairy unit experiment
![2013<br/><span style="color:#000">BioSA grant to support novel dairy unit experiment</span>](https://luodapharma.com/wp-content/uploads/2017/05/517925923-350x120.jpg)
Awarded $50,000 to support the development of experimental dairy at University of Adelaide’s Roseworthy Campus
JUN 2013
Australian Research Council (ARC) Linkage Grant
![JUN 2013<br/><span style="color:#000">Australian Research Council (ARC) Linkage Grant</span>](https://luodapharma.com/wp-content/uploads/2017/05/353040560-350x120.jpg)
Grant worth over $500,000 to help find solutions to the issue of antibiotic resistance in animal health
NOV 2013
Patent application: Pimobendan Liquid Formulation
![NOV 2013<br/><span style="color:#000">Patent application: Pimobendan Liquid Formulation</span>](https://luodapharma.com/wp-content/uploads/2017/05/522110878-350x120.jpg)
Examination phase of the international patent commences globally.
FEB 2014
Patent application: microbial infection treatments
![FEB 2014<br/><span style="color:#000">Patent application: microbial infection treatments</span>](https://luodapharma.com/wp-content/uploads/2017/05/stock-photo-virus-bacteria-cell-algae-microbes-background-suitable-for-custom-scientific-content-448159111-350x120.jpg)
Patent applications submitted to protect the use of ionophores for the treatment of mastitis in dairy cattle and skin infections in dogs
DEC 2014
Distribution & Development agreement signed
![DEC 2014<br/><span style="color:#000">Distribution & Development agreement signed</span>](https://luodapharma.com/wp-content/uploads/2017/05/88837180-350x120.jpg)
Major agreement with a Top 10 Global Pharmaceutical company for the commercialisation of an oral solution of the canine cardiac drug pimodendan
2011-15
Over $2m seed capital already invested in R&D
![2011-15<br/><span style="color:#000">Over $2m seed capital already invested in R&D</span>](https://luodapharma.com/wp-content/uploads/2017/05/200106980-350x120.jpg)
A recent second fund raise has put Luoda in a position where its current portfolio is fully-funded.
JULY 2015
Registration dossier submitted to APVMA
![JULY 2015<br/><span style="color:#000">Registration dossier submitted to APVMA</span>](https://luodapharma.com/wp-content/uploads/2017/05/pills-adjusted-350x120.jpg)
Pimobendan liquid formulation becomes Luoda’s first submission to APVMA for registered status
September 2016
Pimobendan oral solution approved by APVMA and sales as VETMEDIN ORAL SOLUTION commence soon afterwards.